Showing 161 - 180 results of 15,965 for search '(((( ((b large) OR (a large)) decrease ) OR ( i larger decrease ))) OR ( via large decrease ))*', query time: 1.25s Refine Results
  1. 161
  2. 162

    DataSheet1_Adverse childhood experiences, brain function, and psychiatric diagnoses in a large adult clinical cohort.pdf by David B. Keator (19842939)

    Published 2024
    “…However, no study has explored these associations in a large clinical population to identify brain regions that may mediate the relationship between ACEs and psychiatric diagnoses. …”
  3. 163
  4. 164
  5. 165
  6. 166

    Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx by Dewan Zhao (21547445)

    Published 2025
    “…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”
  7. 167
  8. 168

    Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinoma by Hao Shi (158171)

    Published 2025
    “…</p> <p><b>Abbreviation</b>: 3-MA, 3-methyladenine; AL, autolysosome; AP, autophagosome; Baf-A1, bafilomycin A<sub>1</sub>; BARA, β-α repeated autophagy specific domain; BH3, BCL2 homology 3 domain; CCD, coiled-coil domain; CHX, cycloheximide; Co-IP, co-immunoprecipitation; CQ, chloroquine; CTR, control; DAPI, 4′,6-diamidino-2-phenylindole; EBSS, Earle’s balanced salt solution; ECD, evolutionarily conserved domain; EEE, three-tyrosine phosphomimetic mutations Y229E Y233E Y352E; ER, endoplasmic reticulum; FFF, three-tyrosine non-phosphomimetic mutations; FFPE, formalin-fixed paraffin-embedded; FL, full-length; GIST, gastrointestinal stromal tumor; IB, immunoblotting; IHC, immunohistochemistry; KIT-HEK293, KIT stably expressing HEK293 cells; KRT20/CK20, keratin 20; LT, large T-antigen; LT339, MCPyV truncated LT antigen; LTco, codon-optimized MCPyV LT antigen; MCC, Merkel cell carcinoma; MCPyV<sup>−</sup>, MCPyV-negative; MCPyV, Merkel cell polyomavirus; MCPyV<sup>+</sup>, MCPyV-positive; PARP1, poly(ADP-ribose) polymerase 1; PCI, pan-caspase inhibitor; PI, propidium iodide; PtdIns3K, class III phosphatidylinositol 3-kinase; PtdIns3P, phosphatidylinositol-3-phosphate; RB1, RB transcriptional corepressor 1; RTKs, receptor tyrosine kinases; KITLG/SCF, KIT ligand; sT, small T-antigen; sTco, codon-optimized MCPyV sT antigen; T-B, Tat-BECN1; T-S, Tat-scrambled; TEM, transmission electron microscopy.…”
  9. 169
  10. 170

    Decrease in the burst onset latency of the recruited neurons leads to pruning of long delay connections. by Yevhen Tupikov (10319281)

    Published 2021
    “…B: A neuron being recruited initially spikes at a large latency, which allows long delay connections to emerge. …”
  11. 171

    CY-09 Alleviates the Depression-like Behaviors via Inhibiting NLRP3 Inflammasome-Mediated Neuroinflammation in Lipopolysaccharide-Induced Mice by Yu Wang (12152)

    Published 2022
    “…Depression is a serious mental illness, mainly characterized as large mood swings and sleep, diet, and cognitive function disorders. …”
  12. 172
  13. 173
  14. 174

    Presentation_1_Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB.pdf by Morten Aagaard Nielsen (11237429)

    Published 2022
    “…The increase was accompanied by a 4-fold decrease in TNFα production by the 4-1BB<sup>high</sup>Gal-3<sup>+</sup> T cells, after exposure to 4-1BB/Gal-3 complexes. …”
  15. 175

    UV Reconfigurable Shape Memory Polyurethane with a High Recovery Ratio under Large Deformation by Jing Hu (41899)

    Published 2021
    “…The shape memory thermoplastic polyurethane (TPU) generally exhibits a phase-separated structure, in which the hard segments form the hard domains via hydrogen bonds, and plays an important role in shape recovery. …”
  16. 176
  17. 177

    Supplementary Material for: Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease by Fabbrocini G. (7463126)

    Published 2021
    “…<b><i>Objective:</i></b> To evaluate how the burden of HS disease impacts on patient well-being and working activities in a large Italian population over a period of 9 months. …”
  18. 178
  19. 179
  20. 180